Recombinant human erythropoietin (EPO) is the leading biotechnology engineered hormone for treatment of anaemia associated with chronic conditions including kidney failure and cancer. The finding of ...
Erythropoietin (EPO) is a 30.4 kDa glycoprotein comprised of one 165 amino acid residues chain with four glycosylation locations (Figure 1). The hormone is produced naturally in the kidneys, ...
A 65-year-old woman with fourth stage CKD was admitted to a hospital in Wales with a week-long history of shortness of breath and fatigue. A 53-year-old man on home haemodialysis was found to have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback